EGFR mutation testing in blood for guiding EGFR tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis. [electronic resource]
Producer: 20170315Description: e6151 p. digitalISSN:- 1536-5964
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- ErbB Receptors -- blood
- Hematologic Tests
- Humans
- Lung Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- therapeutic use
- Randomized Controlled Trials as Topic
- Survival Analysis
- Systematic Reviews as Topic
- Meta-Analysis as Topic
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.